Skip to main content
IONS
NASDAQ Life Sciences

FDA Greenlights Treatment for Acute Pancreatitis Risk in Severe Hypertriglyceridemia

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$76.98
Mkt Cap
$12.722B
52W Low
$37.32
52W High
$86.74
52W Position info
106% above low
Off High info
11% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

IONS has more than doubled off its 52-week low of $37.32.

Summary

The FDA has approved a new treatment to reduce the risk of acute pancreatitis in adults with severe hypertriglyceridemia. This is a significant regulatory milestone for Ionis, allowing the company to commercialize the drug and open a new revenue stream. This approval follows a period of positive news for Ionis, including strong Q1 results and positive clinical data for other pipeline assets, such as the long-term data for olezarsen announced on June 12th.

At the time of this announcement, IONS was trading at $76.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.7B. The 52-week trading range was $37.32 to $86.74. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Oct 23, 2026, 1:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.93
Real-time Price: $38.80 info
Change: -$4.13 (-10%) info
Market Cap: $6.448B info
IONS
Oct 20, 2026, 9:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $45.20
Real-time Price: $38.80 info
Change: -$6.40 (-14%) info
Market Cap: $6.448B info
IONS
Oct 16, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.56
Real-time Price: $38.80 info
Change: -$4.76 (-11%) info
Market Cap: $6.448B info
IONS
Sep 23, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $45.75
Real-time Price: $38.80 info
Change: -$6.95 (-15%) info
Market Cap: $6.448B info
IONS
Sep 22, 2026, 8:36 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $46.42
Real-time Price: $38.80 info
Change: -$7.62 (-16%) info
Market Cap: $6.448B info